Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aelite is a clinical-stage medical technology company focused on developing long-term, biocompatible solutions for soft tissue augmentation and regenerative medicine. The company's lead product is a proprietary, non-resorbable soft tissue filler designed to provide permanent volume restoration for patients with facial lipoatrophy or significant soft tissue defects. Unlike traditional hyaluronic acid fillers that require frequent re-injection, Aelite's technology utilizes a unique scaffold that encourages natural tissue ingrowth while maintaining structural integrity. The company aims to address unmet needs in both the aesthetic and reconstructive surgery markets by providing a safe, durable alternative to fat grafting and temporary injectables.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aelite.